XML 17 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated deficit
Total
Beginning Balance, Shares at Dec. 31, 2013 66,575,122      
Beginning Balance, Amount at Dec. 31, 2013 $ 666 $ 7,220,612 $ (5,523,792) $ 1,697,486
Stock based compensation - Series A Warrant 848,388 848,388
Stock based compensation - options 59,860 59,860
Net Loss (2,131,396) (2,131,396)
Ending Balance, Shares at Dec. 31, 2014 66,575,122      
Ending Balance, Amount at Dec. 31, 2014 $ 666 8,128,860 (7,655,188) 474,338
Stock based compensation - options   59,122   59,122
Issuance of common stock plus warrants, Shares 1,010,000      
Issuance of common stock plus warrants, Amount $ 10 1,009,990   1,010,000
Exercise of warrants, Shares 196,812      
Exercise of warrants, Amount $ 2 (2)  
Net Loss     (1,318,507) (1,318,507)
Ending Balance, Shares at Dec. 31, 2015 67,781,934      
Ending Balance, Amount at Dec. 31, 2015 $ 678 9,197,970 (8,973,695) 224,953
Stock based compensation - options 287,238 287,238
Exercise of warrants, Shares 2,173,913      
Exercise of warrants, Amount $ 22 999,978 1,000,000
Discount on convertible promissory note due to detachable warrants 340,735 340,735
Discount on convertible promissory note due to beneficial conversion feature 359,265 359,265
Net Loss (1,610,880) (1,610,880)
Ending Balance, Shares at Sep. 30, 2016 69,955,847      
Ending Balance, Amount at Sep. 30, 2016 $ 700 $ 11,185,186 $ (10,584,575) $ 601,311